Author: Poltronieri, Palmiro; Sun, Binlian; Mallardo, Massimo
Title: RNA Viruses: RNA Roles in Pathogenesis, Coreplication and Viral Load Document date: 2015_10_23
ID: 259cspey_12
Snippet: Inhibition of RT activity in cancer cell lines, either by LINE-1-specific RNA interference or by RT inhibitory drugs, was found to reduce proliferation and promote differentiation and to antagonize tumor growth in animal models. Using CsCl density gradients, Alu-and LINE-1-containing DNA:RNA hybrid structures were identified in cancer yet not in normal cell lines [8] . In cancer cells the highly abundant RT activity intercepts various RNA classes.....
Document: Inhibition of RT activity in cancer cell lines, either by LINE-1-specific RNA interference or by RT inhibitory drugs, was found to reduce proliferation and promote differentiation and to antagonize tumor growth in animal models. Using CsCl density gradients, Alu-and LINE-1-containing DNA:RNA hybrid structures were identified in cancer yet not in normal cell lines [8] . In cancer cells the highly abundant RT activity intercepts various RNA classes and reverse transcribes them generating RNA:DNA hybrids. This may impair the formation of double-stranded RNAs required in the production of small regulatory RNAs (miRNA in particular), with a direct impact on gene expression. RT inhibition restores the 'normal' small RNA profile and the regulatory networks that depend on them. Thus, the retrotransposonencoded RT drives a previously unrecognized mechanism crucial to the transformed state in tumor cells.
Search related documents:
Co phrase search for related documents- cell line and double strand: 1, 2
- cell line and double strand rna: 1
- cell line and gene expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- cell line and inhibitory drug: 1, 2
- cell line and normal cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- cell line and regulatory network: 1, 2, 3
- cell line and regulatory rna: 1
- cell line and RNA class: 1, 2, 3
- cell line and RNA interference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- cell line and RNA profile: 1, 2, 3, 4
- cell line and RT activity: 1, 2
- cell line and small RNA profile: 1
- cell line and transcribe reverse: 1
- cell line and tumor cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69
- cell line and tumor growth: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- CsCl density gradient and density gradient: 1, 2
- density gradient and gene expression: 1
- density gradient and RNA interference: 1
- differentiation promote and gene expression: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date